BD OptEIA- Human C3a ELISA Kit_BD Pharmingen-艾美捷科技

BD OptEIA- Human C3a ELISA Kit_BD Pharmingen

艾美捷科技 • 2025年08月19日 15:11:19 • 抗体 • 阅读 14 • 标签

产品信息

抗原名称

C3a

克隆号

(RUO)

BD化合物表

描述
数量/尺寸
零件号
EntrezGene ID
Antibody Coated Wells
N/A
51-27111E
N/A
Detection Antibody
N/A
51-27112E
N/A
Standards
N/A
51-27116E
N/A
Enzyme Concentrate Streptavidin-HRP
N/A
51-9002833
N/A
Standard/Sample Diluent
N/A
51-2708KD
N/A
ELISA Diluent
N/A
51-2707KD
N/A
Wash Concentrate (20X)
100 mL (1 ea)
51-9003738
N/A
TMB One-Step Substrate Reagent
N/A
51-2709KD
N/A
Stop Solution
N/A
51-2608KC
N/A

应用

实验应用

ELISA (Routinely Tested)

文献

研发参考(5) 1. Bokisch, VA, and HJ Muller-Eberhard. Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase. J Clin Invest. 1970; 49:2427-36. (Biology). 2. Ember JA., Jagels MA., Hugli TE. Characterization of complement anaphylatoxins and their biological responses. In: J.E. Volanakis and M.M. Frank, ed. The human complement system in health and disease. Marcel Dekker, Inc; 1998:241-284. 3. Hugli, TE, and HJ Muller-Eberhard. Anaphylatoxins: C3a and C3a. Advances in Immunology. 1978; 26:1-53. (Biology). 4. Matsushita, M and T Fujita. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med. 1992; 176:1497-1502. (Biology). 5. Pfeifer PH, Kawahara MS, Hugli TE. Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation. Clin Chem. 1999; 45(8):1190-1199. (Biology).

BD OptEIA- Human C3a ELISA Kit_BD Pharmingen

相关推荐